A statistician on a NICE committee


  • His prime research interests are in the design and analysis of studies of complex interactions.


The National Institute for Health and Clinical Excellence decides which new therapies should be allowed in the NHS. In Britain it is known as NICE. Some Americans call it a death panel. Mike Campbell works on a NICE appraisal committee. He explains what he does.